Cure Tuberculosis is a five-year activity (2019-2024) implemented by JSI in partnership with University Research Co., LLC (URC) and United States Pharmacopeia (USP) which aims to strengthen the Kyrgyz government’s ability to diagnose, treat, and cure people with drug-resistant tuberculosis (DR-TB). The project activities are aligned with the USAID Global TB Strategy and TB Roadmap implementation pillars: Reach, Cure, Prevent, Innovate, and Sustain. Cure Tuberculosis works through four sub-grantee organizations and in close collaboration with the Kyrgyz Republic’s National Tuberculosis Program (NTP) under the Ministry of Health (MOH) and national partners.
We strive to build lasting relationships to produce better health outcomes for all.
